Kura Oncology (KURA) Receivables - Other (2014 - 2026)
Kura Oncology's Receivables - Other was $31,000 in Q1 2020, down 82.7% from $179,000 a year earlier but up 3.3% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Receivables - Other (2014 - 2026) Analysis & Trends
At the end of FY2019, Receivables - Other at Kura Oncology came in at $30,000, down 86.6% from FY2018.
- Receivables - Other shows a five-year compound annual growth rate of 0.0% (FY2014 to FY2019).
- In earlier years, Receivables - Other was $224,000 in FY2018 (+3.7%), $216,000 in FY2017 (-26.8%), $295,000 in FY2016 (-31.4%) and $430,000 in FY2015.
- Quarterly Receivables - Other has moved between $30,000 (Q4 2019) and $430,000 (Q4 2015) over five years.
- Compared with a year earlier, Receivables - Other has declined for five straight quarters, with an average decline of 42.6% over the last eight quarters.
- The best year-over-year quarter for Receivables - Other over five years was Q1 2016 (growth of 16.3%); the worst was Q4 2019 (a decline of 86.6%).
- Per Business Quant data, KURA's Receivables - Other in the three quarters before Q1 2020 was $30,000 (Q4 2019), $47,000 (Q3 2019) and $111,000 (Q2 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Kura Oncology | 695.52 Mn | -1.56 Bn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.30 Mn |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Dec 31, 2018 | 224,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 216,000.00 |
| Sep 30, 2017 | 209,000.00 |
| Jun 30, 2017 | 304,000.00 |
| Mar 31, 2017 | 341,000.00 |
| Dec 31, 2016 | 295,000.00 |
| Sep 30, 2016 | 261,000.00 |
| Jun 30, 2016 | 286,000.00 |
| Mar 31, 2016 | 406,000.00 |
| Dec 31, 2015 | 430,000.00 |
| Sep 30, 2015 | 379,000.00 |
API Access
Kura Oncology Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();